scholarly article | Q13442814 |
MDMA | Q69488 |
P2093 | author name string | Johnson MP | |
Nichols DE | |||
Oberlender R | |||
Frescas SP | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1662-1668 | |
P577 | publication date | 1991-05-01 | |
P1433 | published in | Journal of Medicinal Chemistry | Q900316 |
P1476 | title | Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphenyl)-2-aminopropane and 5-methoxy-6-methyl-2-aminoindan: similarities to 3,4-(methylenedioxy)methamphetamine (MDMA). | |
P478 | volume | 34 |
Q92575706 | 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α2-adrenergic receptors |
Q41403971 | 4-Methyl-3-nitro-benzaldehyde |
Q31911068 | Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus |
Q34199734 | Aminoindanes--the next wave of 'legal highs'? |
Q33905588 | An analysis of legal highs: do they contain what it says on the tin? |
Q34749393 | Arylethylamine psychotropic recreational drugs: a chemical perspective. |
Q33869570 | Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action |
Q44499276 | Homolytic cleavages in pyridinium ions, an excited state process |
Q34461106 | Indan analogs of fenfluramine and norfenfluramine have reduced neurotoxic potential |
Q28239102 | Initial characterization of PMMA as a discriminative stimulus |
Q42395888 | Locomotor, discriminative stimulus, and place conditioning effects of MDAI in rodents |
Q38123776 | MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update |
Q30251771 | Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. |
Q34607458 | Serotonin neurotoxicity in rats after combined treatment with a dopaminergic agent followed by a nonneurotoxic 3,4-methylenedioxymethamphetamine (MDMA) analogue |
Q34117810 | Serotonin releasing agents. Neurochemical, therapeutic and adverse effects |
Q43921571 | Stimulus generalization by fenfluramine in a quipazine-ketanserin drug discrimination is not dependent on indirect serotonin release |
Q47567624 | Synthetic Aminoindanes: A Summary of Existing Knowledge. |
Q34476946 | The Effect of Selective Serotonin Releasing Agents in the Chronic Mild Stress Model of Depression in Rats |
Q48655807 | The effect of N-methylation on fenfluramine's neurotoxic and pharmacologic actions |
Q34142899 | Therapeutic and adverse actions of serotonin transporter substrates |
Search more.